N. Twidale et al., PREDICTORS OF OUTCOME AFTER RADIOFREQUENCY CATHETER ABLATION OF THE ATRIOVENTRICULAR NODE FOR ATRIAL-FIBRILLATION AND CONGESTIVE-HEART-FAILURE, The American heart journal, 136(4), 1998, pp. 647-657
Background Although radiofrequency catheter ablation of the atrioventr
icular (AV) node is an established treatment for atrial fibrillation (
AF) with uncontrolled ventricular response, factors that predict clini
cal outcome in patients with associated congestive heart failure (CHF)
are unknown. Methods and Results Av node ablation and permanent pacem
aker implantation was performed in 44 consecutive patients (mean age 7
1 +/- 10 years) with CHF and AF associated with uncontrolled ventricul
ar response. Immediately before ablation, mean left ventricular ejecti
on fraction (EF) measured by 2-dimensional echocardiogram was 34.6% +/
- 9.8%, mean exercise tolerance time was 2.6 +/- 1.8 minutes, and mean
quality of life score was 62.3 +/- 19.7 Complete AV block was achieve
d in all 44 patients but was complicated by death in 1 patient from ca
rdiogenic shock soon after ablation. By month after ablation, EF incre
ased to 43.8% +/- 13.7% (P < .01), exercise tolerance time was 4.0 +/-
2.5 minutes (P < .01), and mean quality of life score decreased to 35
.6 +/- 18.1 (P < .01). Improved cardiac performance (increase in EF gr
eater than or equal to 9% over baseline EF) was detected in 20 (45%) o
f the patients. During a mean follow-up of 17 +/- 9 months, 5 patients
died suddenly of presumed ventricular tachyarrhythmia and 4 others di
ed of progressive CHF. Multivariate Cox survival analysis identified b
aseline EF less than or equal to 30%, presence of significant mitral r
egurgitation (>2+) before ablation, and failure to exhibit improved ca
rdiac performance by 1 month after ablation as the only independent pr
edictors of death. Conclusions Baseline variables and failure of EF to
improve soon after AV node ablation identifies patients with CHF and
AF who have a high mortality rate. Adjunctive therapy to reduce sudden
death and progressive heart failure should be evaluated in this subgr
oup.